evans blue has been researched along with aurintricarboxylic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| De Clercq, E; Desmyter, J; Pauwels, R; Schols, D | 1 |
| Aszalos, A; Gergely, P; Patzer, E; Pine, PS; Weaver, JL | 1 |
| Balzarini, J; De Clercq, E; Nakane, H; Ono, K | 1 |
| Balzarini, J; Broder, S; De Clercq, E; Mitsuya, H | 1 |
| Khaled, Z; Stein, CA; Truneh, A; Vlassov, V; Yakubov, L; Zhang, LM | 1 |
| Abello, PA; Buchman, TG; Bulkley, GB; Fidler, SA | 1 |
| Hagar, H; Shah, SV; Ueda, N | 1 |
| Beery, R; Geier, A; Haimsohn, M; Hemi, R; Kanety, H; Karasik, A; Nir, U; Wertheim, N | 1 |
| Bailly, B; Dirr, L; Guillon, P; Van Den Bergh, A; von Itzstein, M | 1 |
1 review(s) available for evans blue and aurintricarboxylic acid
| Article | Year |
|---|---|
Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adsorption; Antibodies, Viral; Antigens, Viral; Aurintricarboxylic Acid; Deltaretrovirus; Deoxycytidine; Foscarnet; Genes, Viral; Glycoproteins; Humans; Interferons; Male; Phosphonoacetic Acid; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Viral; Suramin; Thymidine; Transcription, Genetic; Viral Proteins; Virus Replication; Zalcitabine; Zidovudine | 1986 |
10 other study(ies) available for evans blue and aurintricarboxylic acid
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Topics: Antibodies, Monoclonal; Antiviral Agents; Aurintricarboxylic Acid; CD4-Positive T-Lymphocytes; Cell Line; Cell Separation; Dextran Sulfate; Dextrans; Dose-Response Relationship, Drug; Evans Blue; Flow Cytometry; Heparin; HIV Envelope Protein gp120; HIV-1; Humans; Pentosan Sulfuric Polyester; Suramin | 1990 |
Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120.
Topics: Antibodies, Monoclonal; Aurintricarboxylic Acid; Binding, Competitive; Calcium; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Membrane; Cells, Cultured; Dextran Sulfate; Evans Blue; HIV Envelope Protein gp120; Humans; Membrane Potentials; Receptors, Antigen, T-Cell; Recombinant Proteins; Thiobarbiturates | 1990 |
Differential inhibition of various deoxyribonucleic acid polymerases by Evans blue and aurintricarboxylic acid.
Topics: Animals; Aurintricarboxylic Acid; Azo Compounds; Binding Sites; Binding, Competitive; Cyclohexanecarboxylic Acids; DNA Polymerase I; DNA Primase; DNA-Directed RNA Polymerases; Escherichia coli; Evans Blue; Humans; Leukemia Virus, Murine; Mice; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; RNA Nucleotidyltransferases; Tumor Cells, Cultured | 1988 |
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.
Topics: Animals; Aurintricarboxylic Acid; Azo Compounds; Benzhydryl Compounds; Cell Division; Cyclohexanecarboxylic Acids; Cytopathogenic Effect, Viral; Deltaretrovirus; Evans Blue; Injections, Intraperitoneal; Leukemia L1210; Leukemia, Erythroblastic, Acute; Mammary Neoplasms, Experimental; Mice; Suramin; Viral Proteins | 1986 |
Oligodeoxynucleotides interact with recombinant CD4 at multiple sites.
Topics: Alkylating Agents; Aurintricarboxylic Acid; Binding Sites; Binding, Competitive; CD4 Antigens; Electrophoresis, Polyacrylamide Gel; Evans Blue; Oligodeoxyribonucleotides; Pentosan Sulfuric Polyester; Phosphates; Phosphorus Radioisotopes; Recombinant Proteins; Solutions; Suramin; Trypan Blue | 1993 |
Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin.
Topics: Allopurinol; Animals; Antioxidants; Aorta; Apoptosis; Arsenic; Aurintricarboxylic Acid; Catalase; Cells, Cultured; Cycloheximide; Dimethyl Sulfoxide; DNA; Endonucleases; Endothelium, Vascular; Endotoxins; Evans Blue; Female; Hot Temperature; Iron Chelating Agents; Lipopolysaccharides; Phenanthrolines; Superoxide Dismutase; Swine | 1994 |
Endonuclease induced DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells.
Topics: Animals; Anti-Bacterial Agents; Antimycin A; Aurintricarboxylic Acid; Cell Death; Cell Hypoxia; Coloring Agents; DNA Damage; Endonucleases; Evans Blue; LLC-PK1 Cells; Swine | 1996 |
Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Topics: 3T3 Cells; Animals; Apoptosis; Aurintricarboxylic Acid; Cell Division; Cell Survival; Enzyme Activation; Evans Blue; Humans; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Mice; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Recombinant Proteins; Signal Transduction; Tumor Cells, Cultured; Tyrosine | 2001 |
Drug Repurposing for Therapeutic Discovery against Human Metapneumovirus Infection.
Topics: Aged; Antiviral Agents; Aurintricarboxylic Acid; Drug Repositioning; Evans Blue; Guanosine; Humans; Infant; Metapneumovirus; Mycophenolic Acid; Paramyxoviridae Infections | 2022 |